Intimation for closure of trading window for second quarter of FY 2026-27

September 28, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, “Exchange Plaza”, Corporate Relationship Department, 5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring, Bandra- Kurla Complex Bandra (East), P.J. Towers, Dalal Street, Mumbai – 400 051 Mumbai – 400 001 NSE Symbol: GLENMARK BSE Scrip Code: 532296 ISIN: INE935A01035 ISIN: INE935A01035 Our Reference No. 58/26-27 Our Reference No. 58/26-27 Dear Sir/ Madam, Sub: Closure of Trading Window for dealing in securities of the Company in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended Pursuant to the above Regulations and Company’s Code of Conduct for Prevention of Insider Trading, we wish to inform you that the Trading Window for dealing in securities of Glenmark Pharmaceuticals Limited (the “Company”) shall be closed for the Designated Persons viz. Directors, Key Managerial Personnel, Identified Employees/ Persons of the Company including the Immediate Relatives of the Designated Persons of the Company and for the Connected Persons commencing from October 01, 2026 and the same shall remain closed till the declaration of Unaudited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter ended September 30, 2026 and forty-eight hours thereafter. The date of the Board Meeting of the Company for the declaration of Unaudited Financial Results of the Company for the Second Quarter ended September 30, 2026, will be intimated in due course. This intimation is also being uploaded on the Company’s website at www.glenmarkpharma.com. This is for your information, and you are requested to bring this to the notice of your constituents and take the above information on your record. Thanking You. For Glenmark Pharmaceuticals Limited Rashmi Khandelwal Company Secretary & Compliance Officer ACS - 28839 Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com